Jeffrey B. Landau, Chief Financial Officer at CytomX Therapeutics, Inc. (CTMX), sold 1,477 shares at $1.98 ($3K) on 2023-03-16, disclosed to the SEC on 2023-03-20.
Open-market sale of $3k CTMX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CTMX | SELL | 2023-12-22 | $6K | — | Filing → |
| CTMX | SELL | 2023-09-22 | $5K | — | Filing → |
| CTMX | SELL | 2022-07-21 | $6K | — | Filing → |